Korean AI drug developer secures $14m Series B

AVCJ

Korean AI drug developer secures $14m Series B

09-10-2020

https://www.avcj.com/avcj/news/3020966/korean-ai-drug-developer-secures-usd14m-series-b

Previous: South Korean AI-based pharma firm Oncocross secures $14m Series B 09-11-2020

Next: 'AI신약연구' 온코크로스, VC업고 '제약 협업' 선도 09-09-2020

List